Wockhardt

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE049B01025
  • NSEID: WOCKPHARMA
  • BSEID: 532300
INR
1,264.00
-3.45 (-0.27%)
BSENSE

Apr 02

BSE+NSE Vol: 6.78 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 256229,
    "name": "Wockhardt",
    "stock_name": "Wockhardt",
    "full_name": "Wockhardt Ltd",
    "name_url": "stocks-analysis/wockhardt",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,264.00",
    "chg": -3.45,
    "chgp": "-0.27%",
    "dir": -1,
    "prev_price": "1,267.45",
    "mcapval": "20,205.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 532300,
    "symbol": "WOCKPHARMA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE049B01025",
    "curr_date": "Apr 02",
    "curr_time": "",
    "bse_nse_vol": "6.78 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 02, 2026",
    "traded_date_str": "2026 04 02",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://uat-researchintel.adityabirlamoney.com/ABML-Landingstocks-analysis/wockhardt-256229-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [],
    "total": 0,
    "sid": "256229",
    "stock_news_url": "https://uat-researchintel.adityabirlamoney.com/news/wockhardt-256229"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release",
      "datetime": "30-Mar-2026",
      "details": "Pursuant to Regulation 30 of Listing Regulations please find enclosed Press Release- Wockhardts Zaynich (Zidebactam/ Cefepime) Receives Favourable Recommendation from CDSCOs Subject Expert Committee for Treatment of Gram- Negative Infections.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "25-Mar-2026",
      "details": "This is to inform you that pursuant to Companys Code of Conduct for Regulating Monitoring and Reporting trading by Designated Persons the Trading Window for dealing in equity shares of the Company will be closed from 1st April 2026 until 48 (Forty-eight) hours after the declaration of Audited Financial Results of the Company for the financial year ending 31st March 2026.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "20-Feb-2026",
      "details": "Pursuant to Regulation 30 read with Schedule III Part A Para A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith a copy of the newspaper advertisement published today i.e 20th February 2026 in accordance with the SEBI circular no: HO/38/13/11 (2)2026- MIRSD-POD/1/3750/2026 dated 30th January 2026 regarding the opening of special window for lodgment of the transfer request of shares held in physical form.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Wockhardt Ltd has declared <strong>200%</strong> dividend, ex-date: 17 Nov 16",
          "dt": "2016-11-17",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Wockhardt Ltd has announced <strong>3:10</strong> rights issue, ex-date: 08 Mar 22",
          "dt": "2022-03-08",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}
stock newsNews and Views
Icon
No Recent News for the Company
stock-recommendationAnnouncement

Announcement under Regulation 30 (LODR)-Press Release / Media Release

30-Mar-2026 | Source : BSE

Pursuant to Regulation 30 of Listing Regulations please find enclosed Press Release- Wockhardts Zaynich (Zidebactam/ Cefepime) Receives Favourable Recommendation from CDSCOs Subject Expert Committee for Treatment of Gram- Negative Infections.

Closure of Trading Window

25-Mar-2026 | Source : BSE

This is to inform you that pursuant to Companys Code of Conduct for Regulating Monitoring and Reporting trading by Designated Persons the Trading Window for dealing in equity shares of the Company will be closed from 1st April 2026 until 48 (Forty-eight) hours after the declaration of Audited Financial Results of the Company for the financial year ending 31st March 2026.

Announcement under Regulation 30 (LODR)-Newspaper Publication

20-Feb-2026 | Source : BSE

Pursuant to Regulation 30 read with Schedule III Part A Para A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith a copy of the newspaper advertisement published today i.e 20th February 2026 in accordance with the SEBI circular no: HO/38/13/11 (2)2026- MIRSD-POD/1/3750/2026 dated 30th January 2026 regarding the opening of special window for lodgment of the transfer request of shares held in physical form.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

Wockhardt Ltd has declared 200% dividend, ex-date: 17 Nov 16

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

Wockhardt Ltd has announced 3:10 rights issue, ex-date: 08 Mar 22